Insider Trading activities of Aeglea Biotherapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aeglea Biotherapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aeglea Biotherapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Aeglea Biotherapeutics, Inc. since 2005. The reporting company's ticker symbol is AGLE. The reporting company's CIK number is 1636282.
The total value of stock buying since 2005 is $8,733,882.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aeglea Biotherapeutics, Inc. (AGLE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-02 109,300 $563,882 0 $0 0 $0
2016-04 817,000 $8,170,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aeglea Biotherapeutics, Inc. insiders (AGLE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-02-21 Isaly Samuel D Buy 7,000 5.36 37,520
2017-02-17 Isaly Samuel D Buy 71,800 5.19 372,642
2017-02-16 Isaly Samuel D Buy 30,500 5.04 153,720
2016-04-12 Quinn Anthony Buy 10,000 10.00 100,000
2016-04-12 Cox Russell J. Buy 7,000 10.00 70,000
2016-04-12 Novartis Ag Buy 300,000 10.00 3,000,000
2016-04-12 Lilly Eli & Co Buy 500,000 10.00 5,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of AGLE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aeglea Biotherapeutics, Inc. (symbol AGLE, CIK number 1636282) see the Securities and Exchange Commission (SEC) website.